Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: A comparison with plasma vascular markers

Prostate

Volumn 71, Issue 10, 2011, Pages 1047-1053

  Blann, Andrew D ^a,c   Balakrishnan, Balu ^a   Shantsila, Eduard ^a   Ryan, Peter ^b   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c Dudley Road ^*  (United Kingdom)

Author keywords

circulating endothelial cells; endothelial progenitor cells; prostate cancer; soluble E selectin; von willebrand factor

Indexed keywords

CD146 ANTIGEN; CD309 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN; PROSTATE SPECIFIC ANTIGEN; SOLUBLE ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; TUMOR MARKER; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AGED; ARTICLE; CASE CONTROL STUDY; CIRCULATING ENDOTHELIAL CELL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD; DISEASE PROGRESSION; E-SELECTIN; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; STEM CELLS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 79955803232     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21319     Document Type: Article

References (40)

1. Folkman J,. What is the evidence that tumors are angiogenesis dependent ? J Natl Cancer Inst 1990; 82: 4-6. (Pubitemid 20020880)
2. Jacobs EJ, Hsing AW, Bain EB, Stevens VL, Wang Y, Chen J,. Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 972-977. (Pubitemid 351536431)
3. Lip GYH, Chin BS, Blann AD,. Cancer and the prothrombotic state. Lancet Oncol 2002; 3: 27-34. (Pubitemid 34121143)
4. Houle F, Huot J,. Dysregulation of the endothelial cellular response to oxidative stress in cancer. Mol Carcinog 2006; 45: 362-367. (Pubitemid 43865842)
5. Goon P, Boos C, Lip GYH, Blann AD,. Endothelial progenitor cells and circulating endothelial cells in cancer. Neoplasia 2006; 86: 79-88.
6. Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D, Freeman MR,. Plasma levels of VEGF are increased in patients with metastatic prostate cancer. Urology 1999; 54: 523-527. (Pubitemid 29407032)
7. Blann AD,. Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years. Thromb Haemost 2006; 95: 49-55.
8. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK,. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42: 296-300. (Pubitemid 16244064)
9. Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ,. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68: 122-124. (Pubitemid 23178563)
10. Kumar P, Amin MA, Harlow LA, Polverini PJ, Koch AE,. Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood 2003; 101: 3960-3968. (Pubitemid 36857873)
11. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA,. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150: 644-654. (Pubitemid 23133642)
12. Blann AD, Pretorius A,. Circulating endothelial cells and endothelial progenitor cells: Two sides of the same coin, or two different coins ? Atherosclerosis 2006; 188: 12-18. (Pubitemid 44142547)
13. Dome D, Dobos J, Tovari J, Paku S, Kovacs G, Ostoros G, Timar J,. Circulating bone marrow-derived endothelial progenitor cells: Characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 2008; 73: 186-193. (Pubitemid 351323747)
14. Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, Connelly MC, Rao C, Terstappen LW,. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 2007; 71: 105-113. (Pubitemid 46238939)
15. Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn HJ, Hamacher J, Boneberg EM,. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 2006; 94: 524-531. (Pubitemid 43289756)
16. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, Haubitz M, Hebbel RP, Lip GYH, Mancuso P, Sampol J, Solovey A, Dignat-George F,. Circulating endothelial cells. Biomarkers of vascular disease. Thromb Haemost 2005; 93: 228-235. (Pubitemid 40253726)
17. Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE,. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004; 15: 139-145. (Pubitemid 38139616)
18. Goon PK, Boos CJ, Stonelake PS, Blann AD, Lip GYH,. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison. Thromb Haemost 2006; 96: 45-52. (Pubitemid 44160870)
19. Anonymous. Carcinoma of the prostate. Br Med J 1973; 2: 566-567.
20. Beutler E, Waalen J,. The definition of anemia: What is the lower limit of normal of the blood hemoglobin concentration Blood 2006; 107: 1747-1750. (Pubitemid 43289347)
21. Beutler E, West C,. Hematologic differences between African-Americans and whites: The roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 2005; 106: 740-745. (Pubitemid 40981275)
22. Bain BJ,. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol 1996; 49: 664-666. (Pubitemid 26264395)
23. Al-Mondhiry H, Manni A, Owen J, Gordon R,. Hemostatic effects of hormonal stimulation in patients with metastatic prostate cancer. Am J Hematol 1988; 28: 141-145.
24. Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GYH,. Plasma angiopoietin-1, angiopoietin-2 and tie-2 in breast and prostate cancer: A comparison with VEGF and flt-1. Eur J Clin Invest 2003; 33: 883-890. (Pubitemid 37215044)
25. Duda DG, Cohen KS, di Tomaso E, Au P, Klein RJ, Scadden DT, Willett CG, Jain RK,. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: Implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J Clin Oncol 2006; 24: 1449-1453. (Pubitemid 46622012)
26. Strijbos MH, Gratama JW, Kraan J, Lamers CH, Aden Bakker M, Sleijfer S,. Circulating endothelial cells in oncology: Pitfalls and promises. Br J Cancer 2008; 98: 1731-1735. (Pubitemid 351748848)
27. Duda DG, Cohen KS, Scadden DT, Jain RK,. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2: 805-810. (Pubitemid 46745577)
28. Strijbos MH, Kraan J, den Bakker MA, Lambrecht BN, Sleijfer S, Gratama JW,. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B Clin Cytom 2007; 72: 86-93. (Pubitemid 46365536)
29. Georgiou HD, Namdarian B, Corcoran NM, Costello AJ, Hovens CM,. Circulating endothelial cells as biomarkers of prostate cancer. Nat Clin Pract Urol 2008; 5: 445-454.
30. Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, Desouches C, Blot-Chabaud M, Uzan G, Sampol J, Dignat-George F,. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 2005; 94: 1270-1279. (Pubitemid 41819626)
31. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ,. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995; 376: 517-519.
32. Yamada J, Tsuno N, Kitayama J, Tsuchiya T, Yoneyama S, Asakage M, Okaji Y, Shuno Y, Nishikawa T, Tanaka J, Takahashi K, Nagawa H,. Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation. J Surg Res 2009; 151: 115-120.
33. Li H, Raia V, Bertolini F, Price DK, Figg WD,. Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model. Br J Urol Int 2008; 101: 884-888. (Pubitemid 351347717)
34. Schmidt-Lucke C, Fichtlscherer S, Rössig L, Kämper U, Dimmeler S,. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis 2010; 211: 249-254.
35. Jaumdally RJ, Goon PK, Varma C, Blann AD, Lip GY,. Effects of atorvastatin on circulating CD34+/CD133+/CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. J Intern Med 2010; 267: 385-393.
36. Spiel AO, Mayr FB, Leitner JM, Firbas C, Sieghart W, Jilma B,. Simvastatin and rosuvastatin mobilize endothelial progenitor cells but do not prevent their acute decrease during systemic inflammation. Thromb Res 2008; 123: 108-113.
37. Becher MU, Nickenig G, Werner N,. Regeneration of the vascular compartment. Herz 2010; 35: 342-351.
38. Shaffer RG, Greene S, Arshi A, Supple G, Bantly A, Moore JS, Mohler ER,. Flow cytometric measurement of circulating endothelial cells: The effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006; 70: 56-62.
39. Smythe J, Fox A, Fisher N, Frith E, Harris AL, Watt SM,. Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood. Tissue Eng Part C Methods 2008; 14: 59-67. (Pubitemid 351520452)
40. Ding YT, Kumar S, Yu DC,. The role of endothelial progenitor cells in tumour vasculogenesis. Pathobiology 2008; 75: 265-273.